Aurora Cannabis (ACB) Total Liabilities (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Total Liabilities of $65.1 million for Q1 2026, down 61.74% year-over-year from $170.1 million in Q1 2025, and down 56.25% quarter-over-quarter from $148.8 million in Q4 2025.
Aurora Cannabis (ACB) Total Liabilities (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Total Liabilities for 9 consecutive years, with $65.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 61.74% year-over-year to $65.1 million; the TTM figure through Mar 2026 stood at $65.1 million (down 61.74% YoY), while the FY2026 annual figure was $65.1 million, down 62.93% from the prior year.
- Total Liabilities retreated to $65.1 million in Q1 2026 per ACB's latest filing, from $148.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $441.2 million in Q3 2022 and bottomed at $65.1 million in Q1 2026.
- Historically, Total Liabilities has averaged $216.6 million across 5 years, with a median of $180.9 million in 2024.
- Annual changes were most pronounced in 2025 — Total Liabilities climbed 4.06% — and 2026, when it plunged 61.74%.
- Aurora Cannabis' Total Liabilities stood at $315.9 million in 2022, then plunged by 39.79% to $190.2 million in 2023, then dropped by 4.37% to $181.9 million in 2024, then dropped by 18.22% to $148.8 million in 2025, then tumbled by 56.25% to $65.1 million in 2026.
- Business Quant data shows ACB's Total Liabilities at $65.1 million in Q1 2026, $148.8 million in Q4 2025, and $137.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 67.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.09 Mn |
| Dec 31, 2025 | 148.77 Mn |
| Sep 30, 2025 | 137.89 Mn |
| Jun 30, 2025 | 179.82 Mn |
| Mar 31, 2025 | 170.10 Mn |
| Dec 31, 2024 | 181.92 Mn |
| Sep 30, 2024 | 165.52 Mn |
| Jun 30, 2024 | 172.80 Mn |
| Mar 31, 2024 | 175.73 Mn |
| Dec 31, 2023 | 190.23 Mn |
| Sep 30, 2023 | 200.90 Mn |
| Jun 30, 2023 | 241.39 Mn |
| Mar 31, 2023 | 299.29 Mn |
| Dec 31, 2022 | 315.94 Mn |
| Sep 30, 2022 | 441.21 Mn |
| Mar 31, 2022 | 379.08 Mn |
| Dec 31, 2021 | 421.05 Mn |
| Sep 30, 2021 | 425.28 Mn |
| Jun 30, 2021 | 203,381.79 |
| Mar 31, 2021 | 519.31 Mn |